Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis

被引：2

作者：

Hattori, Yutaka ^{[1
]}

Miyakawa, Yoshitaka ^{[2
]}

Yokoyama, Kenji ^{[2
]}

Yamada, Taketo ^{[3
]}

Du, Wenlin ^{[3
]}

Jinzaki, Masahiro ^{[4
]}

Shinmoto, Hiroshi ^{[4
]}

Okamoto, Shinichiro ^{[2
]}

机构：

[1] Keio Univ, Fac Pharm, Div Clin Physiol & Therapeut, Minato Ku, Tokyo 1058512, Japan

[2] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 1058512, Japan

[3] Keio Univ, Sch Med, Dept Pathol, Tokyo 1058512, Japan

[4] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo 1058512, Japan

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2011年 / 93卷 / 01期

关键词：

MYELOID METAPLASIA; EFFICACY;

D O I：

10.1007/s12185-010-0733-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：129 / 131

页数：3

共 10 条

[1]

Abgrall JF, 2006, HAEMATOLOGICA, V91, P1027

[2] Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia [J].

Barosi, G ;

Grossi, A ;

Comotti, B ;

Musto, P ;

Gamba, G ;

Marchetti, M .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) :78-83

[3] Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: A phase II trial [J].

Marchetti, M ;

Barosi, G ;

Balestri, F ;

Viarengo, G ;

Gentili, S ;

Barulli, S ;

Demory, JL ;

Ilariucci, F ;

Volpe, A ;

Bordessoule, D ;

Grossi, A ;

Le Bousse-Kerdiles, MC ;

Caenazzo, A ;

Pecci, A ;

Falcone, A ;

Broccia, G ;

Bendotti, C ;

Bauduer, F ;

Buccisano, F ;

Dupriez, B .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :424-431

[4] A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia [J].

Mesa, RA ;

Steensma, DP ;

Pardanani, A ;

Li, CY ;

Elliott, M ;

Kaufmann, SH ;

Wiseman, G ;

Gray, LA ;

Schroeder, GE ;

Reeder, T ;

Zeldis, JB ;

Tefferi, A .

BLOOD, 2003, 101 (07) :2534-2541

[5] Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study [J].

Piccaluga, PP ;

Visani, G ;

Pileri, SA ;

Ascani, S ;

Grafone, T ;

Isidori, A ;

Malagola, M ;

Finelli, C ;

Martinelli, G ;

Ricci, P ;

Baccarani, M ;

Tura, S .

LEUKEMIA, 2002, 16 (09) :1609-1614

[6] Lenalidomide Plus Prednisone Results in Durable Clinical, Histopathologic, and Molecular Responses in Patients With Myelofibrosis [J].

Quintas-Cardama, Alfonso ;

Kantarjian, Hagop M. ;

Manshouri, Taghi ;

Thomas, Deborah ;

Cortes, Jorge ;

Ravandi, Farhad ;

Garcia-Manero, Guillermo ;

Ferrajoli, Alessandra ;

Bueso-Ramos, Carlos ;

Verstovsek, Srdan .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4760-4766

[7] Thalidomide for the treatment of idiopathic myelofibrosis [J].

Strupp, C ;

Germing, U ;

Scherer, A ;

Kündgen, A ;

Mödder, U ;

Gattermann, N ;

Haas, R .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (01) :52-57

[8] Lenalidomide therapy in myelofibrosis with myeloid metaplasia [J].

Tefferi, Ayalew ;

Cortes, Jorge ;

Verstovsek, Srdan ;

Mesa, Ruben A. ;

Thomas, Deborah ;

Lasho, Terra L. ;

Hogan, William J. ;

Litzow, Mark R. ;

Allred, Jacob B. ;

Jones, Dan ;

Byrne, Catriona ;

Zeldis, Jerome B. ;

Ketterling, Rhett P. ;

McClure, Rebecca F. ;

Giles, Francis ;

Kantarjian, Hagop M. .

BLOOD, 2006, 108 (04) :1158-1164

[9] Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis [J].

Tefferi, Ayalew ;

Verstovsek, Srdan ;

Barosi, Giovanni ;

Passamonti, Francesco ;

Roboz, Gail J. ;

Gisslinger, Heinz ;

Paquette, Ronald L. ;

Cervantes, Francisco ;

Rivera, Candido E. ;

Deeg, H. Joachim ;

Thiele, Juergen ;

Kvasnicka, Hans M. ;

Vardiman, James W. ;

Zhang, Yanming ;

Bekele, B. Nebiyou ;

Mesa, Ruben A. ;

Gale, Robert P. ;

Kantarjian, Hagop M. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4563-4569

[10] Thalidomide therapy for myelofibrosis with myeloid metaplasia [J].

Thomas, DA ;

Giles, FJ ;

Albitar, M ;

Cortes, JE ;

Verstovsek, S ;

Faderl, S ;

O'Brien, SM ;

Garcia-Manero, G ;

Keating, MJ ;

Pierce, S ;

Zeldis, J ;

Kantarjian, HM .

CANCER, 2006, 106 (09) :1974-1984

← 1 →